RxDoctor Payments Data

Anna Debenedetto, MD

Dermatology · Rochester, NYNPI 1346658069

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $35,298 of the $41,804 with a category attached, or 84.4%. 12 manufacturers reported payments, led by AbbVie at 33.1% of the total. Reporting peaked in 2022 at $21,388 and has fallen 85.7% since, to $3,059 in 2025. Among dermatology clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$41,804in general payments, 2019–2025

Across 68 payments — averaging $614.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$14K
  • Sanofi$9K
  • Incyte Corporation$9K
  • Regeneron$8K
  • Regeneron Healthcare Solutions, Inc.$733
  • Novartis$537
  • plus $615 from 6 others
$709,064in research payments, 2019–2025

Across 391 payments — averaging $1813.46 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Incyte Corporation$424K
  • Pfizer$252K
  • Eli Lilly$21K
  • Novartis$8K
  • Kiniksa Pharmaceuticals, Ltd.$3K
  • Regeneron$1K

What the payments were for

  • Consulting fees$35,29884%
  • Grants$1,0002%
  • Travel & lodging$2,6576%
  • Food & beverage$2,5786%
  • Education$2721%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$41,804 in reported general payments places this provider in the 90th percentile of 1,151 dermatology providers in New York.

See all dermatology providers in New York

Medicare billing

Part B allowed, 2024
$22,303
Medicare patients
204
Services billed
489

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other dermatology in Rochester

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →